NVST Stock Analysis — Envista Holdings
Sector: Healthcare
AI Verdict
At 17.8x forward earnings with a moat in dental consumables and a 426.0% growth forecast, this is cheap for the growth you're getting if those numbers hold up.
Competitive Moat
Envista Holdings specializes in dental equipment and consumables, benefiting from entrenched relationships with dental practices and recurring demand for replacement parts and supplies. Their defensibility comes from a broad product portfolio and integration into dental workflows, making switching costly for practitioners.
Summary
Envista is drawing attention for its forecasted 426.0% jump in earnings per share over the next year.
Where It Stands
NVST trades at 17.8x next year's earnings, well below the healthcare sector median of 22x, while analysts expect a massive 426.0% EPS growth.
Key Metrics
- Trailing P/E: 93.9x
- Forward P/E: 17.8x
- PEG Ratio: 0.22
- Earnings Growth: +4.3%
- Revenue Growth: +0.1%
- 52-Week High: $30.42
- 52-Week Low: $18.77
Analyst Consensus
12 Buy · 10 Hold · 0 Sell (22 analysts)
Bull Case
The forward P/E of 17.8x combined with 426.0% expected EPS growth makes NVST cheap for the growth on offer.
Bear Case
If the forward P/E reverts to the sector median of 22x without delivering on the 426.0% EPS growth, the stock could see a sharp pullback as expectations reset.
Catalyst to Watch
Watch for quarterly earnings reports to confirm whether the explosive EPS growth materializes as forecasted.